Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Hepatocyte growth factor levels in Legionella pneumonia: A retrospective study

Authors: Futoshi Higa, Morikazu Akamine, Makoto Furugen, Kenji Hibiya, Michio Koide, Maki Tamayose, Yuichiro Tamaki, Syusaku Haranaga, Noriko Arakaki, Satomi Yara, Masao Tateyama, Jiro Fujita

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Hepatocyte growth factor (HGF) is known to be involved in the resolution of pulmonary inflammation and repair of acute lung injury. Legionella pneumonia is sometimes complicated by acute lung injury. Our study aimed to determine the role of serum HGF levels in Legionella pneumonia.

Methods

Sera from patients with Legionella pneumonia (42 cases), other bacterial pneumonia (33 cases), pulmonary tuberculosis (19 cases), and normal controls (29 cases) were collected. The serum HGF levels for each serum sample were determined by sandwich ELISA. Clinical and laboratory data were collected by reviewing the medical charts.

Results

Serum HGF levels were higher in patients with Legionella pneumonia than in those with other bacterial pneumonia, pulmonary tuberculosis, and controls. The HGF levels were compared with white blood cell counts, C-reactive protein, Alanine amino- transferase, and lactate dehydrogenase (LDH). The HGF levels were correlated to serum LDH levels. Moreover, serum HGF levels were significantly higher in non-survivors than in survivors.

Conclusions

HGF levels increased in severer pneumonia caused by Legionella, suggesting that HGF might play a significant role in the Legionella pneumonia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ware LB, Matthay MA: Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol. 2002, 282 (5): L924-940.CrossRefPubMed Ware LB, Matthay MA: Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol. 2002, 282 (5): L924-940.CrossRefPubMed
2.
go back to reference Morimoto K, Amano H, Sonoda F, Baba M, Senba M, Yoshimine H, Yamamoto H, Ii T, Oishi K, Nagatake T: Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol. 2001, 24 (5): 608-615.CrossRefPubMed Morimoto K, Amano H, Sonoda F, Baba M, Senba M, Yoshimine H, Yamamoto H, Ii T, Oishi K, Nagatake T: Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol. 2001, 24 (5): 608-615.CrossRefPubMed
3.
go back to reference Jaffre S, Dehoux M, Paugam C, Grenier A, Chollet-Martin S, Stern JB, Mantz J, Aubier M, Crestani B: Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. Am J Physiol Lung Cell Mol Physiol. 2002, 282 (2): L310-315.CrossRefPubMed Jaffre S, Dehoux M, Paugam C, Grenier A, Chollet-Martin S, Stern JB, Mantz J, Aubier M, Crestani B: Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. Am J Physiol Lung Cell Mol Physiol. 2002, 282 (2): L310-315.CrossRefPubMed
4.
go back to reference Hojo SFJ, Yamadori I, Kishimoto T, Miyazaki H, Obayashi Y, Yamaji Y, Takahara J: Serial measurements of plasma hepatocyte growth factor in patients with pneumonia following cancer chemotherapy. J Infect Chemother. 1996, 2: 49-51. 10.1007/BF02355198.CrossRef Hojo SFJ, Yamadori I, Kishimoto T, Miyazaki H, Obayashi Y, Yamaji Y, Takahara J: Serial measurements of plasma hepatocyte growth factor in patients with pneumonia following cancer chemotherapy. J Infect Chemother. 1996, 2: 49-51. 10.1007/BF02355198.CrossRef
5.
go back to reference Nayeri F, Millinger E, Nilsson I, Zetterstrom , Brudin L, Forsberg P: Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med. 2002, 96 (2): 115-119. 10.1053/rmed.2001.1225.CrossRefPubMed Nayeri F, Millinger E, Nilsson I, Zetterstrom , Brudin L, Forsberg P: Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med. 2002, 96 (2): 115-119. 10.1053/rmed.2001.1225.CrossRefPubMed
6.
go back to reference Abednazari H, Xu J, Millinger E, Brudin L, Forsberg P, Nayeri F: Hepatocyte growth factor is a better indicator of therapeutic response than C-reactive protein within the first day of treatment in pneumonia. Chemotherapy. 2006, 52 (5): 260-263. 10.1159/000094868.CrossRefPubMed Abednazari H, Xu J, Millinger E, Brudin L, Forsberg P, Nayeri F: Hepatocyte growth factor is a better indicator of therapeutic response than C-reactive protein within the first day of treatment in pneumonia. Chemotherapy. 2006, 52 (5): 260-263. 10.1159/000094868.CrossRefPubMed
7.
go back to reference Verghese GM, McCormick-Shannon K, Mason RJ, Matthay MA: Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am J Respir Crit Care Med. 1998, 158 (2): 386-394.CrossRefPubMed Verghese GM, McCormick-Shannon K, Mason RJ, Matthay MA: Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am J Respir Crit Care Med. 1998, 158 (2): 386-394.CrossRefPubMed
8.
go back to reference Demello D, Kierol-Andrews L, Scalise PJ: Severe sepsis and acute respiratory distress syndrome from community-acquired legionella pneumonia: case report. Am J Crit Care. 2007, 16 (3): 320-317.PubMed Demello D, Kierol-Andrews L, Scalise PJ: Severe sepsis and acute respiratory distress syndrome from community-acquired legionella pneumonia: case report. Am J Crit Care. 2007, 16 (3): 320-317.PubMed
9.
go back to reference Nayeri F, Brudin L, Darelid J, Nilsson I, Fryden A, Soderstrom C, Forsberg P: Hepatocyte growth factor may act as an early therapeutic predictor in pneumonia. Scand J Infect Dis. 2002, 34 (7): 500-504. 10.1080/00365540110080890.CrossRefPubMed Nayeri F, Brudin L, Darelid J, Nilsson I, Fryden A, Soderstrom C, Forsberg P: Hepatocyte growth factor may act as an early therapeutic predictor in pneumonia. Scand J Infect Dis. 2002, 34 (7): 500-504. 10.1080/00365540110080890.CrossRefPubMed
10.
go back to reference Dominguez A, Alvarez J, Sabria M, Carmona G, Torner N, Oviedo M, Cayla J, Minguell S, Barrabeig I, Sala M, et al: Factors influencing the case-fatality rate of Legionnaires' disease. Int J Tuberc Lung Dis. 2009, 13 (3): 407-412.PubMed Dominguez A, Alvarez J, Sabria M, Carmona G, Torner N, Oviedo M, Cayla J, Minguell S, Barrabeig I, Sala M, et al: Factors influencing the case-fatality rate of Legionnaires' disease. Int J Tuberc Lung Dis. 2009, 13 (3): 407-412.PubMed
11.
go back to reference von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Luck C: Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis. 2008, 46 (9): 1356-1364. 10.1086/586741.CrossRefPubMed von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Luck C: Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis. 2008, 46 (9): 1356-1364. 10.1086/586741.CrossRefPubMed
12.
go back to reference Jespersen S, Sogaard OS, Schonheyder HC, Fine MJ, Ostergaard L: Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: a Danish historical cohort study. BMC Infect Dis. 2010, 10: 124-10.1186/1471-2334-10-124.CrossRefPubMedPubMedCentral Jespersen S, Sogaard OS, Schonheyder HC, Fine MJ, Ostergaard L: Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: a Danish historical cohort study. BMC Infect Dis. 2010, 10: 124-10.1186/1471-2334-10-124.CrossRefPubMedPubMedCentral
13.
go back to reference Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997, 336 (4): 243-250. 10.1056/NEJM199701233360402.CrossRefPubMed Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997, 336 (4): 243-250. 10.1056/NEJM199701233360402.CrossRefPubMed
14.
go back to reference Nayeri F, Nilsson I, Skude G, Brudin L, Soderstrom C: Hepatocyte growth factor (HGF) in patients with pneumonia: a comparison between survivors and non-survivors. Scand J Infect Dis. 1998, 30 (4): 405-409. 10.1080/00365549850160729.CrossRefPubMed Nayeri F, Nilsson I, Skude G, Brudin L, Soderstrom C: Hepatocyte growth factor (HGF) in patients with pneumonia: a comparison between survivors and non-survivors. Scand J Infect Dis. 1998, 30 (4): 405-409. 10.1080/00365549850160729.CrossRefPubMed
15.
go back to reference Maeda J, Ueki N, Hada T, Higashino K: Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am J Respir Crit Care Med. 1995, 152 (5 Pt 1): 1587-1591.CrossRefPubMed Maeda J, Ueki N, Hada T, Higashino K: Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am J Respir Crit Care Med. 1995, 152 (5 Pt 1): 1587-1591.CrossRefPubMed
Metadata
Title
Hepatocyte growth factor levels in Legionella pneumonia: A retrospective study
Authors
Futoshi Higa
Morikazu Akamine
Makoto Furugen
Kenji Hibiya
Michio Koide
Maki Tamayose
Yuichiro Tamaki
Syusaku Haranaga
Noriko Arakaki
Satomi Yara
Masao Tateyama
Jiro Fujita
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-74

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.